Cited by 71Diabetes Management and ResearchElectrochemical sensors and biosensorsDiabetes Treatment and Management

Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy

Open access
Clarke, William L., Kovatchev, Boris·2007·Journal of Diabetes Science and Technology

Abstract

Continuous glucose sensors (CGS) offer the potential to greatly change the lives of people with diabetes. Even though two of these systems (Guardian RT, Medtronic, Northridge, CA, and DexCom STS, DexCom, San Diego, CA) have been approved by the Food and Drug Administration for use as adjuncts to self-blood glucose monitoring (SBGM), questions remain concerning the accuracy of these devices. When considering accuracy, two distinct approaches should be emphasized: (1) numerical and (2) clinical. Because CGS data are a process in time, each of these two approaches includes two subtypes of accuracy: point and rate. Conventional statistics such as correlation coefficients, mean and median relative absolute differences, and International Standards Organization criteria are measures of numerical point accuracy. A new measure, the R deviation, is introduced to quantify numerical rate accuracy. Error-grid analysis (Clarke EGA) measures clinical point accuracy. The only measure of both clinical point accuracy and rate accuracy is continuous glucose error-grid analysis. This analysis is a combination of two components, P-EGA measuring point accuracy and R-EGA measuring rate accuracy, which are designed to assess the information that distinguishes continuous glucose measurements from intermittent SBGM determinations. Further, a better understanding of the source of the error associated with time lag and its effect on CGS readings may improve sensor output. Finally, the reliability of the CGS sensors, in terms of initial calibration and long-term application, needs to be assessed carefully if current CGS systems are to be used as hypoglycemia monitors or incorporated in the future design of closed loop (artificial pancreas) systems.

Integrity signals

Registry

Crossref · 10.1177/193229680700100510

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current numerical and clinical accuracy criteria for CGM include linear regressions and correlation coefficients, MAD and MARD, Clarke Error Grid Analysis, and ISO criteria.

    “Current numerical and clinical accuracy criteria for CGM includes linear regressions and correlation coefficients; mean (or median) absolute and relative absolute difference (MAD and MARD); Clarke Error Grid Analysis (Clarke EGA); and, International Standard Organization (ISO) criteria.76”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Clarke, W. L., & Kovatchev, B.
Affiliations
University of Virginia (US)
Corresponding author
Clarke, William L.
Venue
Journal of Diabetes Science and Technology
Published
2007-09
Volume
1
Issue
5
Pages
669-675
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2098977530
Cited by
71
References
23
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 2 · 2015: 8 · 2014: 10 · 2013: 3 · 2012: 3
Type
conference abstract
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk051562-23)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-051562)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Engineering › Electrical and Electronic Engineering › Electrochemical sensors and biosensors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
sensor accuracy, diabetes mellitus, error grid analysis, time delay, sensor calibration, artificial pancreas, self-monitoring of blood glucose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review